Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions：A Preliminary Lung Centered Study

Carcinoma of the Lungs Clinical Trial

Official title:

Evaluation of Clinical Significance and Feasibility of CT Guided Biopsy of Double Site Lesions：A Preliminary Lung Centered Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04960631
• Other study ID #: M2018060
• Status: Completed
• Start date: March 1, 2018
• Est. completion date: May 31, 2018

Study information

• Verified date: June 2021
• Source: Peking University Third Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study aims to explore the clinical significance and feasibility of double site biopsy by analyzing the pathological characteristics and the incidence of main complications of CT guided puncture biopsy of lung and other parts coexisting lesions.

Description:

CT guided biopsy is minimally invasive, accurate and low cost. It is often used as an important diagnostic method when the clinical suspect of malignant disease or the treatment effect of the disease is not good. In patients with suspected malignant lung disease, metastasis of other parts of lung, pulmonary door, mediastinum, bone, and distant soft tissue may be combined at the same time. It is the key link of clinical work to evaluate the nature of these coexisting lesions accurately and choose appropriate treatment methods. At present, there is little clinical study on lung centered double site biopsy. This study aims to explore the clinical significance and feasibility of double site biopsy by analyzing the pathological characteristics and the incidence of main complications of CT guided puncture biopsy of lung and other parts coexisting lesions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 134
• Est. completion date: May 31, 2018
• Est. primary completion date: April 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• patients with suspected malignancy

• underwent dual site CT guided biopsy in the Third Hospital of Peking University

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Carcinoma of the Lungs
• Lung Neoplasms

Intervention

Diagnostic Test:
• Double site CT guided needle biopsy
Double site CT guided needle biopsy

Locations

Country	Name	City	State
China	Peking University Third Hospital	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Peking University Third Hospital

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	for the combination of two site biopsies	The incidence of 4 kinds of combined pathological results in different lesion location groups was analyzed.	up to 2weeks
Primary	for the combination of two site biopsy approaches 1	The incidence of pneumothorax on the surgical side after unilateral lung biopsy	up to 2weeks
Primary	for the combination of two site biopsy approaches 2	the incidence of pneumothorax on the surgical side after bilateral lung biopsy	up to 2weeks
Primary	for the combination of two site biopsy approaches 3	the incidence of intra tissue hemorrhage after biopsy were statistically analyzed.	up to 2weeks